TGA Approval

EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle (180859)

ARTG ID

180859

ARTG Name

EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle

Sponsor

Bayer Australia Ltd

ARTG Date

March 7, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BAYER AUSTRALIA LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-02075-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-PI-01387-3

Ingredient Name

Aflibercept

Empowering clinical research with data-driven insights and AI-powered tools.

EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle (180859) - TGA 批准文号 | MedPath